A Phase I single-blind, randomised, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single and multiple rising doses of SIM0709 in healthy participants

What you commit to

• Study type: Interventional · Phase 1
• Planned participants: 88
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for healthy adults to test the safety and how the body handles SIM0709, compared with a placebo.

Age

18 Years to 64 Years

Sex

All sexes can join.

This trial only enrols healthy participants. The registry sentence this rests on: A Phase I single-blind, randomised, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single and multiple rising doses of SIM0709 in healthy participants

Read by machine on 9 Nov 2026.

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details